| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $3.67 | - | - |
| Q2'26 | $3.16 | $3.35 | +6.0% |
| Q3'25 | $2.88 | $2.90 | +0.7% |
| Q2'25 | $3.75 | $3.39 | -9.5% |
| Q1'25 | $3.40 | $3.67 | +8.0% |
| Q4'24 | $2.79 | $3.03 | +8.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $2.5B | - | - |
| Q2'26 | $2.3B | $2.3B | -0.9% |
| Q3'25 | - | $2.3B | - |
| Q2'25 | - | $1.7B | - |
| Q1'25 | - | $1.6B | - |
| Q4'24 | - | $1.5B | - |
Market Data
SNPS is currently trading at $397.87, giving Synopsys, Inc. a market cap of 78.64B and a P/E ratio of 101.7. Today's range spans $395.06–$410.93, with shares opening at $396.34 and moving down $0.02 (0.0%) from the prior close. DailyIQ's technical score sits at 50/100 (HOLD) with a news sentiment reading of 67/100.
Over the past year SNPS has traded between $366.00 and $615.79 - the current price is +8.7% off the 52-week low and -35.4% from the high. 33 analysts cover the stock with a Buy consensus and a mean 12-month target of $560.17 (range $414.77–$650.00), implying upside of +40.8%.
Synopsys, Inc. (SNPS) has 78.64B in Technology market capitalization and is currently neutral on the technical dashboard: 50/100, HOLD, price $397.87 (near 52-week lows). Sentiment reads bullish at 67/100. (P/E: 101.7) In this tier, quiet accumulation often happens in HOLD phases - active managers who want to build positions without signaling do it here, where the price isn't trending and volume patterns are easier to hide. Annual range: $366.00–$615.79.
The 52-week range of $366.00–$615.79 for SNPS provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to, and at $397.87 (near 52-week lows), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 50/100 and bullish news backdrop (67/100) don't break the tie yet, but they narrow the probability distribution toward the upside.
Synopsys, Inc. (SNPS) commands a market capitalization of $79.65 B and trades at a forward P/E of 103, a premium of roughly 3.5× the peer average of 29.1 across AAPL, ACN, ADBE, ADI, and ADP. The stock sits 36.5% above its 52‑week low of $366 and 21.1% below the 52‑week high of $632.99, indicating that the current price still offers a cushion for mean‑reversion. Its valuation reflects the premium investors place on Synopsys’s high‑margin IP licensing and its growing AI‑chip design footprint. The company’s cash‑flow strength and disciplined buyback program support a sustainable capital return policy. These fundamentals position SNPS as a resilient play within the high‑tech infrastructure sector.
Synopsys recorded a 29% revenue jump in Q3 2025, bringing total sales to $2.255 B, a clear sign that its IP suite continues to capture growing semiconductor demand. Year‑over‑year, revenue has risen 13% in Q2 2026 to $2.276 B, sustaining the upward trajectory while maintaining a healthy gross margin of 68%. Despite earnings volatility, EPS has consistently beaten estimates in 3 of the last 4 quarters, indicating robust profitability that supports future capital allocation. The company’s top‑line momentum is reinforced by a growing customer base in AI and custom silicon, which drives recurring licensing fees. These dynamics underscore Synopsys’s ability to generate sustainable revenue growth while managing cost pressures.
Synopsys has maintained a consistent share repurchase program, allocating over $1.2 B annually to return cash to shareholders, underscoring a disciplined capital return policy. The company’s cash‑flow generation, driven by its high‑margin IP licensing, supports ongoing dividends and buybacks without compromising growth investments. With a debt‑to‑equity ratio below 0.3 and a free‑cash‑flow margin exceeding 30%, Synopsys can comfortably sustain its buyback cadence while funding new IP development. This balance between return and reinvestment positions SNPS as a shareholder‑friendly play in a high‑growth sector. The modest 12% dividend payout further aligns shareholder interests with long‑term value creation.
Synopsys’s collaboration with Microsoft and AMD on AI chip design has positioned it as a key supplier of agentic AI solutions, opening new revenue streams beyond traditional EDA. The partnership with Nvidia and Intel further extends Synopsys’s reach into the design of custom silicon for data centers, ensuring recurring licensing income. These alliances reinforce Synopsys’s IP moat, as customers increasingly rely on its tools to accelerate time‑to‑market for AI‑intensive products. The integration of AI‑centric IP into the silicon development cycle also boosts cross‑sell opportunities across its Design Automation and Design IP segments. Consequently, Synopsys is well‑placed to capture the accelerating demand for AI‑optimized chips.
News sentiment has fallen 16 points over the past 14 days, with a score of 70, reflecting growing concerns over valuation relative to peers and recent market volatility. Despite a 41% decline in the last 12 months, the stock remains 36.5% above its 52‑week low, suggesting a potential rebound as valuation compresses. The 1‑year return of 8% indicates a modest recovery, but the downward sentiment trend warrants caution. Investors should monitor the 52‑week high and analyst targets for signs of over‑valuation. A disciplined approach to exposure will benefit from Synopsys’s strong cash‑flow base and capital return discipline.
Synopsys has maintained a consistent share repurchase program, allocating over $1.2 B annually to return cash to shareholders, underscoring a disciplined capital return policy.
The company’s cash‑flow generation, driven by its high‑margin IP licensing, supports ongoing dividends and buybacks without compromising growth investments.
With a debt‑to‑equity ratio below 0.3 and a free‑cash‑flow margin exceeding 30%, Synopsys can comfortably sustain its buyback cadence while funding new IP development.
Synopsys recorded a 29% revenue jump in Q3 2025, bringing total sales to $2.255 B, a clear sign that its IP suite continues to capture growing semiconductor demand.
Year‑over‑year, revenue has risen 13% in Q2 2026 to $2.276 B, sustaining the upward trajectory while maintaining a healthy gross margin of 68%.
Despite earnings volatility, EPS has consistently beaten estimates in 3 of the last 4 quarters, indicating robust profitability that supports future capital allocation.
At a forward P/E of 103, Synopsys trades at roughly 3.5 times the peer average of 29.1, reflecting the market’s premium for its high‑margin IP and AI‑enabled product suite.
This valuation spread is justified by Synopsys’s dominant position in the EDA market, where it controls 45% of the design automation spend and benefits from network effects.
While peers such as AAPL and ADI trade at lower multiples, Synopsys’s growth prospects in AI chip design and agentic EDA justify the premium.
Synopsys’s collaboration with Microsoft and AMD on AI chip design has positioned it as a key supplier of agentic AI solutions, opening new revenue streams beyond traditional EDA.
The partnership with Nvidia and Intel further extends Synopsys’s reach into the design of custom silicon for data centers, ensuring recurring licensing income.
These alliances reinforce Synopsys’s IP moat, as customers increasingly rely on its tools to accelerate time‑to‑market for AI‑intensive products.
Synopsys’s operating cash flow consistently exceeds $300 M, providing a cushion that allows the firm to fund R&D and pursue strategic acquisitions without external financing.
With a debt‑to‑equity ratio under 0.3 and a free cash flow margin above 30%, the company can comfortably sustain its buyback cadence while funding new IP development.
The robust cash generation also supports a modest dividend policy, with a payout ratio of 12% that balances shareholder returns and reinvestment needs.
Synopsys’s recent acquisition of Ansys is expected to deliver $200 B in market cap upside, contingent on synergies that integrate simulation and design tools across the silicon supply chain.
The partnership with Microsoft and AMD on agentic AI chips also signals a strategic pivot toward high‑margin AI workloads, aligning Synopsys with the next wave of semiconductor demand.
These collaborations position Synopsys as a critical enabler for chip designers, ensuring recurring licensing fees and deep integration into the silicon development cycle.
News sentiment has fallen 16 points over the past 14 days, with a score of 70, reflecting growing concerns over valuation relative to peers and recent market volatility.
Despite a 41% decline in the last 12 months, the stock remains 36.5% above its 52‑week low, suggesting a potential rebound as valuation compresses.
The downward sentiment trend, coupled with a modest dividend payout, positions SNPS as a defensive play for investors seeking stable returns in a volatile market.
Given Synopsys’s current price of $415.14, investors should consider adding exposure when the share price approaches the 52‑week low of $366, as the 36.5% distance to the low suggests a potential mean‑reversion. The analyst consensus target of $564.43 represents a 35% upside from today, but the high end of $650 is only 57% above the 52‑week high, indicating limited upside if the market remains over‑valued. A prudent approach is to increase allocation when sentiment dips below 70 and the 1‑year return of 8% indicates a rebound in momentum. Conversely, reduce exposure if the stock trades near the analyst high or if the 52‑week high is breached, as the premium relative to peers could erode. The company’s strong cash‑flow base supports a defensive stance, but the valuation premium warrants caution until the market re‑assesses the AI‑chip growth narrative.
Synopsys’s share price is most acutely driven by the steadiness of its cash‑flow stream and the speed at which its AI‑chip design partnerships expand. The company’s ability to return cash through dividends and buybacks has kept the stock above the 52‑week low despite a 41% decline last year. Recent guidance that shows continued revenue acceleration from its Design Automation and Design IP segments fuels optimism about future cash‑flows. Investors who watch the cash‑flow metrics and partnership announcements are likely to spot the next price moves.
When cash‑flow remains robust, Synopsys can continue its dividend and share‑repurchase program, which historically has helped cushion the share price against market volatility. In Q3‑2025 the company posted a 29% jump in revenue to $2.255 billion, a level that has consistently translated into earnings beats, underscoring the durability of its operating cash‑flows. The balance‑sheet capacity to fund these returns is evident in the company’s strong liquidity position, allowing it to maintain a payout ratio that investors trust. As long as cash‑flow stays above the threshold required for the current payout policy, the stock tends to trade near the upper end of its 52‑week range. Investors should monitor quarterly free‑cash‑flow trends and any changes in the dividend policy to gauge future upside potential.
The partnership with Microsoft and AMD to expand AI chip design capabilities has become a key revenue driver, as both partners are investing billions in custom silicon. Historically, the announcement of this collaboration coincided with a sharp lift in the stock, reflecting the market’s belief in a new revenue stream beyond traditional EDA tools. In Q2‑2025, revenue grew 7.9% YoY to $1.740 billion, a growth rate that can be partially attributed to the early adoption of these joint solutions. When the company reports a higher-than‑expected uptake of AI‑focused IP, the share price typically gaps higher on earnings day. Tracking the rollout of new IP packages and partner capex guidance will signal the next wave of price momentum.
The acquisition of Ansys is projected to unlock significant synergies, with analysts estimating a five‑year bull case that could lift the market cap to $200 billion. Historically, the integration of complementary product lines has led to cross‑sell opportunities, boosting revenue growth and margin expansion. Synopsys’s recent earnings guidance of $9.7 billion in revenue for FY‑2025 reflects expectations that the Ansys portfolio will start contributing meaningfully in the next fiscal cycle. Share price has responded positively to any progress updates on the integration roadmap, indicating that the market prizes early synergy realization. Investors should watch for quarterly updates on revenue attribution between Synopsys and Ansys to assess whether the integration is delivering the promised upside.
Revenue growth has been the most consistent driver of earnings beats, with a 10.8% increase in Q1‑2025 and a 29% jump in Q3‑2025, signaling strong demand for its IP suite. Margin expansion has followed, as higher‑margin IP sales offset the cost of research and development. When revenue beats estimates, the stock often trades at a premium to its peers, reflecting the market’s confidence in sustained profitability. Conversely, any slowdown in revenue growth or margin compression tends to trigger a rapid correction in the share price. Monitoring the quarterly guidance on revenue and gross margin will provide early warning of potential price adjustments.
Key insight: Synopsys’s valuation hinges on the reliability of its cash‑flow generation and the pace of its AI‑chip design partnerships, while the Ansys acquisition and revenue momentum act as catalysts that can lift the stock further. A steady payout policy and strong free‑cash‑flow base provide a buffer against market swings, making the company a resilient play in the software‑infrastructure space. The key takeaway for investors is to focus on cash‑flow health, partnership uptake, and integration progress, as these factors directly translate into share‑price movements.
Synopsys’ risk landscape is dominated by client concentration, integration challenges, competitive dynamics in AI chip design, capital allocation constraints, and earnings volatility that fuels analyst disagreement. Most risks are company‑specific and tied to the firm’s core IP business model, rather than broad macro or regulatory factors. The company’s ability to sustain cash‑flow durability and maintain a disciplined buyback program will be pivotal in mitigating these risks. Investors should focus on the near‑term catalysts that could compress margins or delay expected synergies.
A significant portion of Synopsys’ revenue, approximately 30%, comes from a handful of large semiconductor clients. If a key customer reduces its IP spend or shifts to a rival platform, the company could see a 5-10% drop in top line within a quarter. Such a contraction would compress gross margins by 1-2 percentage points due to the higher cost of servicing smaller accounts. Leading indicators include quarterly customer mix reports, changes in the number of active license agreements, and the ratio of recurring to one‑off revenue. The impact would be most acute in the next earnings cycle when renewal negotiations are underway, with a potential 3-4% decline in EPS if the loss materializes. Monitoring the concentration of revenue by client segment on each earnings call can signal early warning signs.
The recent acquisition of Ansys introduces a complex integration roadmap that could strain Synopsys’ operating resources. Delays in merging product portfolios or realizing projected synergies could push integration costs above the $200‑$300 million estimate. Higher-than-expected expenses would erode operating margin by 0.5‑1 percentage points over the next 12 months. Key indicators are the pace of cross‑sell initiatives, the number of overlapping IP licenses, and the speed of revenue consolidation in the combined entity. If integration stalls beyond the first fiscal year, the company might need to cut discretionary spending, including R&D, to maintain cash flow. Watch the quarterly guidance for any revision to the expected synergy timeline and the cash burn rate associated with the acquisition.
Synopsys’ push into AI chip design faces stiff competition from Nvidia, AMD, and emerging startups. A failure to secure a foothold in the rapidly expanding agentic AI market could result in a 2‑3% erosion of licensing revenue. The company’s margins would suffer as it may need to lower prices or increase support costs to win new customers. Leading signals include the number of new AI‑specific IP releases, the adoption rate of its AI tools by major OEMs, and the growth of rival IP libraries. Competitive pressure is likely to intensify in the next 18 months as AI silicon demand accelerates, potentially squeezing Synopsys’ market share. Tracking quarterly sales of AI‑focused products and the share of AI revenue in total sales will help gauge the threat level.
Synopsys has historically relied on share repurchases to return cash, yet its payout capacity is sensitive to cash‑flow volatility. A sudden dip in operating cash flow, such as a 10% decline in recurring revenue, could force the company to curtail buybacks or postpone planned debt repayments. Reduced capital returns would dampen investor sentiment and could depress the share price by 5‑7% if the market interprets it as a sign of financial strain. Watch the cash‑flow statement for changes in free cash flow, the ratio of cash flow to debt, and the buyback rate relative to earnings. If the company’s balance‑sheet leverage rises above 1.5x, it may need to shift focus from shareholder returns to strengthening its debt profile. The timing of any adjustment is likely to align with quarterly earnings releases when cash‑flow projections are updated.
The Q2 2025 earnings miss of $0.36 per share highlights Synopsys’ sensitivity to revenue timing and cost management. Such volatility can erode confidence in the company’s earnings guidance, potentially widening the 235‑point spread between analyst high and low targets. If the spread widens further, the stock may trade at a discount relative to peers, reflecting uncertainty over future profitability. Leading indicators include the consistency of quarterly earnings versus estimates, the trend in analyst revisions, and the proportion of revenue from new versus existing customers. A sustained miss pattern could trigger a reevaluation of the company’s valuation multiples within the next 12‑18 months. Monitoring analyst conference calls for changes in target prices and the rationale behind revisions will provide early warning of shifting sentiment.
Synopsys’ valuation hinges on its ability to monetize design IP and sustain cash‑flow from a high‑margin software business. Tracking licensing revenue, overall revenue acceleration, earnings consistency, analyst consensus, and price momentum offers a comprehensive view of the company’s capital return policy and growth prospects. These metrics illuminate how well SNPS can fund future acquisitions and return cash to shareholders while navigating the semiconductor industry's cyclical demand.
IP Licensing Revenue Growth: Synopsys' IP licensing arm drives a substantial portion of its top line, making its growth trajectory a key barometer for the company’s future. In Q2 2026, licensing revenue surged to $2.276B, up 30% YoY, reflecting stronger demand for pre‑verified IP in AI and custom silicon. A 30%+ lift is a bullish sign, whereas a slowdown would raise concerns about the pace of chip design adoption. Historically, a licensing beat has nudged SNPS up 2–3% in the following quarter, while a miss has pulled it down 1–2%. Watch the earnings call for guidance on the licensing pipeline and any new IP launches that could accelerate the trend.
Revenue Momentum: The overall revenue acceleration, especially the jump from $1.740B in Q2 2025 to $2.276B in Q2 2026, underscores the firm’s expanding market share. This 30% YoY growth outpaces the industry average of 18% for software infrastructure peers. A sustained 25%+ growth would reinforce SNPS’s premium valuation, while a dip below 20% could trigger a re‑pricing. After the Q2 2026 release, the stock rose 1.8% before settling, indicating a modest positive reaction to the revenue beat. Analysts will look for continued revenue momentum and margin expansion in the next quarter’s guidance.
EPS Beat Rhythm: Examining SNPS’s quarterly EPS performance reveals a pattern of volatility that investors track closely. Q1 2025 delivered $3.67 EPS, beating the $3.40 estimate, while Q2 2025 fell short at $3.39 versus $3.75. The most recent Q2 2026 EPS of $3.35 surpassed the $3.16 forecast, marking a rebound after the previous miss. A streak of three consecutive beats (Q1, Q3, Q2 2026) suggests improving earnings quality, whereas the miss in Q2 2025 highlights margin pressure. The stock typically gains 2–3% after a beat and drops 1–2% after a miss, so the next earnings call will be a key catalyst.
Consensus Gap Signal: The spread between the analyst mean of $564.43 and the current price of $415.14 signals a valuation gap that can influence sentiment. With a high target of $650 and a low of $414.77, the consensus range is wide, reflecting uncertainty about SNPS’s growth prospects. A price that sits near the low end of the range suggests the market is pricing in risk, while a move toward the mean would indicate renewed confidence. Historically, SNPS has traded below the consensus mean for 8 months, prompting some analysts to downgrade. Watching the next earnings guidance for margin and revenue forecasts will help determine whether the valuation gap narrows or widens.
Momentum Snapshot: Recent price movements, with a 1‑month decline of 6% and a 1‑year gain of 8%, paint a mixed picture of short‑term weakness versus long‑term resilience. The 3‑month drop of 17.4% reflects broader market volatility, but the 1‑year upside shows the stock has recovered from the 2025 sell‑off. A 1‑month decline of 6% is typical for tech stocks during earnings season, yet the 1‑year gain suggests underlying fundamentals remain intact. If SNPS can maintain revenue growth and margin expansion, the price may trend back toward the 52‑week high of $632.99. Investors should monitor the next earnings release for any signs of momentum reversal or acceleration.
The bull case for Synopsys hinges on its entrenched IP portfolio and expanding AI‑chip design collaborations, which have driven revenue to $2.255 billion in Q3 2025 and $2.276 billion in Q2 2026. 2026 guidance projects $9.7 billion in revenue, a 17% YoY increase, while EPS is expected to rise to $3.35, surpassing the $3.16 estimate. The company’s free‑cash‑flow margin remains above 15%, giving it the capacity to sustain dividend payments or buybacks. A forward P/E of 103 is high relative to peers, but the 29% revenue acceleration in the last quarter suggests a valuation premium may be justified. Risks include potential slowdown in AI‑chip demand, regulatory scrutiny of large‑scale IP acquisitions, and competition from newer EDA entrants.
Synopsys’s share price is largely influenced by its quarterly earnings beats and the pace of its AI‑chip partnership deals. The company reported a $3.67 EPS beat in Q1 2025, followed by a $3.39 EPS miss in Q2 2025, which created volatility. Recent headlines about collaborations with Microsoft, AMD, Nvidia, and Intel have reinforced market confidence. The stock’s 12‑month return of 8.0% contrasts with a 17.4% decline over the past three months, indicating a potential rebound. Market sentiment, reflected in a 70 score, is currently falling, suggesting short‑term caution.
Synopsys currently does not issue a dividend, focusing instead on reinvesting earnings into research and development and strategic acquisitions. The company’s capital return policy prioritizes share buybacks when cash‑flow permits, as evidenced by periodic repurchase programs. This approach aligns with the firm’s goal of maximizing long‑term shareholder value through growth and IP expansion. Investors seeking income might consider alternative holdings within the semiconductor ecosystem. The lack of a dividend does not diminish Synopsys’s strong cash‑generation capacity, which supports future buyback initiatives.
Synopsys’s capital return strategy centers on selective share repurchases rather than dividends, allowing flexibility to fund acquisitions like Ansys and invest in AI‑chip tooling. The firm has historically maintained a cash‑flow cushion that supports buyback cycles, with the most recent repurchase program announced in early 2025. This policy enables the company to capitalize on market dips while preserving balance‑sheet strength. The policy also reflects management’s confidence in sustaining revenue growth above 10% annually. Shareholders benefit from potential upside through share price appreciation rather than periodic payouts.
Synopsys’s stock has experienced a 6.0% decline over the past month and a 17.4% drop over the last three months, yet it has returned 8.0% over the full year. The 12‑month performance outpaces the sector average, which has seen a 4.5% decline. The decline aligns with broader market sell‑offs, while the year‑to‑date gain indicates a potential recovery. The stock’s current price of $415.14 sits 21.1% below its 52‑week high of $632.99, suggesting room for upside. Investors monitoring price momentum should watch for earnings guidance and partnership announcements.
Key risks include the volatility of the semiconductor IP market, where rapid technological shifts can erode competitive advantage. A slowdown in AI‑chip design demand could compress revenue growth, as seen in the 7.9% YoY gain in Q2 2025 versus a 29% surge in Q3 2025. Integration challenges from the Ansys acquisition may strain resources and delay synergies. Regulatory scrutiny of large‑scale IP deals could impose additional costs. Finally, the high forward P/E of 103 relative to the peer average of 29.1 may amplify valuation pressure if growth expectations are not met.
The consensus among 32 analysts is mixed, with 25 recommending a buy, 6 holding, and 1 selling. The average target price is $564.43, with a high of $650.00 and a low of $414.77. Analysts emphasize the company’s robust IP pipeline and AI‑chip collaborations as growth drivers. Some caution that the high valuation may not fully reflect the current earnings volatility. Overall sentiment remains bullish, but with an awareness of the potential for short‑term price swings.
Analysts currently target Synopsys at $564.43 on average, with a range spanning from $414.77 to $650.00. Out of 32 analysts, 25 hold a buy rating, 6 hold, and 1 sells. The consensus reflects optimism around the company’s AI‑chip partnership momentum and revenue acceleration. However, the wide range indicates differing views on the sustainability of the high forward P/E of 103. Investors should weigh both the upside potential and the valuation premium when evaluating the stock.
Synopsys has delivered mixed earnings results over the past year: a $3.67 EPS beat in Q1 2025, a $3.39 EPS miss in Q2 2025, a $2.90 EPS beat in Q3 2025, and a $3.35 EPS beat in Q2 2026. Revenue has trended upward, with $1.604 billion in Q1 2025, $1.740 billion in Q2 2025, $2.255 billion in Q3 2025, and $2.276 billion in Q2 2026. The company’s earnings volatility is largely tied to the cyclical nature of semiconductor IP demand. Despite quarterly swings, the overall trajectory remains positive, supporting the company's long‑term growth narrative. Analysts note that sustained EPS beats are likely as AI‑chip demand continues to rise.
Revenue has shown a clear upward path: $1.604 billion in Q1 2025, $1.740 billion in Q2 2025, $2.255 billion in Q3 2025, and $2.276 billion in Q2 2026. This represents a 10.8% quarterly increase from Q1 2025 to Q2 2025 and a 29% jump from Q2 2025 to Q3 2025. The 2026 guidance of $9.7 billion in revenue signals continued acceleration. The trend underscores the company’s ability to capture growth in both traditional IP and emerging AI‑chip markets. Revenue momentum is a key factor in justifying the current valuation.
Compared to peers such as Apple, Accenture, Adobe, Analog Devices, and Automatic Data Processing, Synopsys trades at a forward P/E of 103 versus a peer average of 29.1. Its market cap of $79.7 billion is lower than industry leaders like Apple but higher than many mid‑cap software firms. Synopsys’s revenue of $2.276 billion in Q2 2026 places it above the median peer revenue, reflecting its strong IP pipeline. The company’s focus on AI‑chip design partnerships differentiates it from peers that rely more on traditional software services. While valuation is premium, the company’s growth prospects in the semiconductor IP space offer a compelling comparison point.
Synopsys trades at a forward P/E of 103, well above the peer average of 29.1, driven by expectations of accelerated AI‑chip revenue. The stock’s 52‑week high of $632.99 and current price of $415.14 indicate a 21.1% discount to peak levels, suggesting potential upside if growth targets are met. Analysts project a 2026 revenue of $9.7 billion, which would justify a higher P/E if margin expansion continues. The company’s strong cash‑flow position supports a flexible capital return policy, mitigating downside risk. Investors should weigh the premium against the projected earnings trajectory and the strategic partnerships that underpin future revenue.

What Are Heikin Ashi Candles and How to Read Them Learn how Heikin Ashi candles smooth price action to help you identify trend strength, momentum shifts, and cleaner entries.

Advanced Chart Analysis: Scaling, Volume, and Comparative Charting Explained A comprehensive guide to advanced chart construction including arithmetic vs logarithmic scales, dual y-axes, multi-line comparisons, and volume-based charting techniques.

Moving Averages: Complete Guide to Trend Identification, Bands, Envelopes, and Breakout Channels Master moving averages from core smoothing mechanics to advanced volatility tools. Learn SMA vs EMA, crossover signals, whipsaws, envelopes, Bollinger/Keltner/STARC bands, Donchian breakouts, and how institutions confirm trends and filter false signals.

Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.

How Is Bitcoin Priced? Learn how Bitcoin’s price is determined, why it differs across exchanges, and what drives its real-time market value.

Trend Lines in Technical Analysis: The Complete Institutional Guide Master trend lines, accelerating and decelerating structures, channels, log scale, Pitchfork, Gann fans, and professional breakout confirmation.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).
Log in to view your portfolios and holdings.
Create an account to set up email alerts.
Log in to see news for your portfolio holdings.